Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 9

Results For "MIT"

5636 News Found

Sumitomo Pharma America launches as new combined organization
News | July 11, 2023

Sumitomo Pharma America launches as new combined organization

SMPA's diverse portfolio includes six marketed products and a robust pipeline of early- to late-stage assets


Capex commitment likely to be in the range of Rs. 200-300 Cr: Dr. R. Ananthanarayanan, CEO, Sajjan India
interviews | June 20, 2023

Capex commitment likely to be in the range of Rs. 200-300 Cr: Dr. R. Ananthanarayanan, CEO, Sajjan India

Sajjan India Limited is looking for expansion, both organically and through acquisitions, to achieve the planned growth


InnoCan submits new patent applications for advanced pain relief technology
News | June 13, 2023

InnoCan submits new patent applications for advanced pain relief technology

The application is in line with Innocan's strategy to expand the scope of its combined magnesium and cannabis topical solution


Astellas submits new drug application for Zolbetuximab in Japan
News | June 13, 2023

Astellas submits new drug application for Zolbetuximab in Japan

Ministry of Health, Labour and Welfare to evaluate zolbetuximab as treatment option for patients with advanced gastric and gastroesophageal cancers


Brinton appoints Amit Jain as President & Head of Domestic Business
People | June 07, 2023

Brinton appoints Amit Jain as President & Head of Domestic Business

Jain will have oversight of Brinton's domestic operations, including business development, sales, and marketing


GlaxoSmithKline Pharmaceuticals posts consolidated Q4 FY2023 PAT at Rs. 133.43 Cr
News | May 22, 2023

GlaxoSmithKline Pharmaceuticals posts consolidated Q4 FY2023 PAT at Rs. 133.43 Cr

The company has reported total income of Rs. 815.11 crores during the period ended March 31, 2023


USFDA Advisory Committee votes  n Lynparza plus Abiraterone and Prednisone  for prostate cancer
Drug Approval | May 03, 2023

USFDA Advisory Committee votes n Lynparza plus Abiraterone and Prednisone for prostate cancer

The committee voted that FDA should restrict use of LYNPARZA plus abi/pred to these BRCAm mCRPC patients


Mitsui Chemicals ‘Super-Bond’ dental adhesive to launch in Brazil
News | May 01, 2023

Mitsui Chemicals ‘Super-Bond’ dental adhesive to launch in Brazil

Super-Bond is made up of a polymerization initiator, a liquid and a polymer powder